| --- | --- | --- | |----------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

证券代码：300972 证券简称：万辰集团 公告编号：2024-099 二、监事会会议审议情况 全体与会监事经认真审议，形成以下决议： （一）审议通过《关于公司<2024 年第三季度报告>的议案》 经审议，监事会认为：公司《2024 年第三季度报告》的编制和审核程序符合 相关法律、法规的要求，报告内容真实、准确、完整地反映了公司 2024 年第三 季度经营的实际情况，不存在任何虚假记载、误导性陈述或重大遗漏。 具体内容详见公司披露于巨潮资讯网（www.cninfo.com.cn）的《2024 年第 三季度报告》。 福建万辰生物科技集团股份有限公司 第四届监事会第二十一次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 福建万辰生物科技集团股份有限公司（以下简称"公司"）第四届监事会第 二十一次会议于 2024 年 10 月 28 日在公司会议室以现场结合通讯方式召开，本 次监事会会议通知于 2024 年 10 月 25 日以书面、电子邮件的形式向公司全体监 事发出。会议应参与表决监事 3 名，实际参与表决监事 3 名，会议由 ...

Financial Performance - Revenue for the third quarter reached 9.70 billion yuan, a year-on-year increase of 261.32%[3] - Net profit attributable to shareholders of the listed company was 83.13 million yuan, up 263.06% year-on-year[3] - Revenue for the first nine months of 2024 increased by 320.63% to 20.61 billion yuan, driven by the expansion of the company's snack retail business[9] - Net profit for the first nine months of 2024 surged by 352.09% to 344.68 million yuan, with the snack retail business contributing 392 million yuan in net profit[10] - Total revenue for the period reached 20,613,100,328.64 yuan, a substantial increase from 4,900,487,114.84 yuan in the same period last year[22] - Operating profit for the quarter was 582.94 million yuan, compared to a loss of 129.50 million yuan in the same period last year[23] - Net profit attributable to the parent company's shareholders was 84.07 million yuan, an improvement from a loss of 56.56 million yuan in the previous year[23] - Total comprehensive income for the period was 344.68 million yuan, compared to a loss of 136.73 million yuan in the previous year[24] - Basic earnings per share were 0.5001 yuan, compared to a loss of 0.3684 yuan in the same period last year[24] Cash Flow and Financial Position - Operating cash flow for the period was 972.48 million yuan, a significant increase of 1,696.18% year-on-year[3] - Operating cash flow for the first nine months of 2024 increased by 1696.18% to 972.48 million yuan, primarily due to increased cash inflows from the expanded snack retail business[11] - The company's investment activities resulted in a net cash outflow of 370.58 million yuan, a 203.26% increase, primarily due to payments for equity acquisitions[11] - The company's financing activities generated a net cash inflow of 455.06 million yuan, a 51.03% increase, driven by equity financing and increased bank borrowings[11] - Operating cash flow for the quarter was RMB 972.48 million, compared to a negative RMB 60.93 million in the same period last year[26] - Total cash outflow from operating activities was RMB 22.84 billion, a significant increase from RMB 5.82 billion in the previous year[26] - Cash paid for goods and services reached RMB 21.52 billion, up from RMB 5.14 billion year-over-year[26] - Cash paid for employee compensation and benefits was RMB 572.45 million, compared to RMB 260.82 million in the same period last year[26] - Net cash used in investing activities was RMB 370.58 million, compared to RMB 122.20 million in the previous year[26] - Cash inflow from financing activities totaled RMB 1.07 billion, up from RMB 438.43 million year-over-year[26] - Net cash inflow from financing activities was RMB 455.06 million, compared to RMB 301.30 million in the same period last year[26] - The company's cash and cash equivalents at the end of the quarter stood at RMB 2.21 billion, a significant increase from RMB 233.21 million at the end of the previous year[26] Assets and Liabilities - Total assets as of the end of the reporting period were 6.46 billion yuan, an increase of 64.53% compared to the end of the previous year[3] - Inventory increased by 143.77% to 1.79 billion yuan due to the expansion of the discount snack business[7] - Accounts payable rose by 102.43% to 1.91 billion yuan, driven by the growth of the discount snack business[7] - Short-term borrowings increased by 60.75% to 821.07 million yuan, reflecting higher working capital needs[7] - Capital reserve grew by 43.60% to 522.85 million yuan, mainly due to equity financing[8] - Minority shareholders' equity surged by 453.08% to 279.02 million yuan, reflecting increased profits from the discount snack business[8] - The company's total assets increased to 6,458,418,402.46 yuan as of September 30, 2024, compared to 3,925,354,361.68 yuan at the beginning of the year, reflecting significant growth[19][20][21] - The company's monetary funds grew to 2,292,794,509.98 yuan, up from 1,209,689,850.18 yuan at the beginning of the year[19] - Inventory increased to 1,787,572,807.31 yuan, compared to 733,288,606.20 yuan at the start of the year[19] - Total liabilities rose to 5,266,424,254.49 yuan, up from 3,229,545,195.69 yuan at the beginning of the year[21] - Shareholders' equity increased to 1,191,994,147.97 yuan, compared to 695,809,165.99 yuan at the start of the year[21] - The company's short-term borrowings increased to 821,071,023.52 yuan, up from 510,765,675.17 yuan at the beginning of the year[20] - Accounts payable grew to 1,909,239,404.42 yuan, compared to 943,174,069.62 yuan at the start of the year[20] Snack Retail Business Performance - The snack retail business generated 20.23 billion yuan in revenue and 392 million yuan in net profit for the first nine months of 2024, with Q3 revenue reaching 9.55 billion yuan and net profit at 201 million yuan[10] - The company's snack retail business saw a significant increase in sales and management expenses, rising by 258.57% and 144.49% respectively, due to business expansion[9] - Income tax expenses surged by 4130.68% to 229.64 million yuan, mainly due to the expansion of the snack retail business[9] - Sales revenue from goods and services reached 23.22 billion yuan, a significant increase from 5.59 billion yuan in the previous period[25] Expenses and Costs - The company's total operating costs reached 20,052,037,551.11 yuan, compared to 5,028,819,170.26 yuan in the same period last year[22] - Sales expenses increased to 894.92 million yuan, up from 249.58 million yuan in the previous period[23] - Management expenses rose to 622.18 million yuan, compared to 254.48 million yuan in the previous period[23] - R&D expenses were 2.98 million yuan, slightly higher than the 2.07 million yuan in the previous period[23] - Financial expenses increased to 28.86 million yuan, up from 18.10 million yuan in the previous period[23] - Interest income was 10.03 million yuan, a significant increase from 1.15 million yuan in the previous period[23] Shareholder and Equity Information - The company granted 770,000 second-class restricted shares to 20 incentive recipients at a price of 15.17 yuan per share on August 15, 2024[16] - The company completed the registration of 2,285,285 restricted shares for 144 incentive recipients, increasing the total share capital from 177,199,647 shares to 179,484,932 shares[17] - The company's largest shareholder, Fujian Mimosa Agricultural Development Co., Ltd., holds 40,949,000 shares, accounting for 23.11% of the total shares[13] - The company's second-largest shareholder, Zhangzhou Jinwanchen Investment Co., Ltd., holds 29,935,000 shares, accounting for 16.89% of the total shares[13] - The company's third-largest shareholder, Peng Dejian, holds 6,777,485 shares, accounting for 3.83% of the total shares[13] - The company's fourth-largest shareholder, Shenzhen Dingxin Enterprise Consulting Management Co., Ltd., holds 3,877,215 shares, accounting for 2.19% of the total shares[13] - The company's fifth-largest shareholder, Shenzhen Weishunzhengxin Investment Co., Ltd., holds 3,718,413 shares, accounting for 2.10% of the total shares[13] - The company's sixth-largest shareholder, China Merchants Bank Co., Ltd. - Orient Red Ruihe Three-Year Regular Open Hybrid Securities Investment Fund, holds 2,095,392 shares, accounting for 1.18% of the total shares[13] - The company's seventh-largest shareholder, China Merchants Bank Co., Ltd. - Orient Red Hengyang Five-Year Regular Open Hybrid Securities Investment Fund, holds 2,037,588 shares, accounting for 1.15% of the total shares[13] - A 7.5% stake in the company, totaling 13,461,370 shares, was transferred between shareholders, with no change in controlling shareholders[18] Investments and Acquisitions - The company plans to acquire 49% equity of Nanjing Wanhao Commercial Management Co., Ltd. for 294 million yuan to optimize industrial resources and enhance competitiveness[17] - The company invested RMB 294.00 million in new investments during the quarter[26] Other Financial Information - The company's other income increased by 569.55% to 40.26 million yuan, mainly due to increased government subsidies[9] - The company's asset disposal losses increased by 439.38% to 8.66 million yuan, primarily due to increased losses from the disposal of non-current assets[9] - The third quarter report was unaudited, as stated by the company's board[27]

国浩律师（北京）事务所 关于 福建万辰生物科技集团股份有限公司 2022 年限制性股票激励计划首次授予部分第二 个归属期及预留授予部分第一个归属期归属条 件成就、部分限制性股票作废事项 之 法律意见书 北京市朝阳区东三环北路 38 号泰康金融大厦 9 层 邮编：100026 9 th Floor, Taikang Financial Tower, No. 38North RoadEast ThirdRing, Chaoyang District, Beijing, 100026, China 电话/Tel: 010-65890699 传真/Fax: 010-65176800 网址/Website: http://www.grandall.com.cn 二〇二四年十月 | 释 义 2 | | --- | | 一、本次归属和本次作废的批准与授权 4 | | 二、本次归属的具体情况 6 | | 三、本次作废的具体情况 10 | | 四、结论意见 10 | 在本《法律意见书》中，除非文义另有所指，下列词语具有下述含义： | 万辰集团、公司 | 指 | 福建万辰生物科技集团股份有限公司 | | --- | --- | ...

证券代码：300972 证券简称：万辰集团 公告编号：2024-098 福建万辰生物科技集团股份有限公司 第四届董事会第二十次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 福建万辰生物科技集团股份有限公司（以下简称"公司"）第四届董事会第 二十次会议于 2024 年 10 月 28 日在公司会议室以现场结合通讯方式召开，本次 董事会会议通知于 2024 年 10 月 25 日以书面、电子邮件的形式向公司全体董事 发出。会议应参与表决董事 9 名，实际参与表决董事 9 名，会议由公司董事长王 健坤主持，公司监事和高级管理人员列席会议。本次会议的召开符合《中华人民 共和国公司法》等相关法律法规以及《福建万辰生物科技集团股份有限公司章程》 的规定。 二、董事会会议审议情况 全体与会董事经认真审议，形成以下决议： （一）审议通过《关于公司<2024 年第三季度报告>的议案》 根据相关法律法规、中国证监会和深圳证券交易所的相关规定，公司编制了 《2024 年第三季度报告》，本议案在提交董事会审议前，已经公司董事会审计委 员会审议通 ...

上海信公轶禾企业管理咨询有限公司 关于 福建万辰生物科技集团股份有限公司 2022 年限制性股票激励计划 首次授予部分第二个归属期及预留授予部 分第一个归属期归属相关事项 之 独立财务顾问报告 独立财务顾问： 二〇二四年十月 | 第一章 | 声 明 3 | | --- | --- | | 第二章 | 义 5 释 | | 第三章 | 基本假设 6 | | 第四章 | 本激励计划履行的审批程序 7 | | 第五章 | 本激励计划首次授予部分第二个归属期及预留授予部分第一个归属期 | | | 归属条件成就情况 10 | | | 一、本激励计划本次归属条件成就的情况说明 10 | | | 二、本激励计划本次归属情况 12 | | 第六章 | 独立财务顾问的核查意见 15 | 二、本独立财务顾问本着勤勉、审慎、对上市公司全体股东尽责的态度，依 据客观公正的原则，对本激励计划事项进行了尽职调查义务，有充分理由确信所 发表的专业意见与上市公司披露的文件内容不存在实质性差异，并对本独立财务 顾问报告的真实性、准确性和完整性承担法律责任。 三、本独立财务顾问所表达的意见基于下述假设前提之上：国家现行法律、 法规无重大变化，上市 ...

公司监事会根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股权激励 管理办法》（以下简称"《管理办法》"）、《深圳证券交易所创业板股票上市 规则》（以下简称"《上市规则》"）、《深圳证券交易所创业板上市公司自律 监管指南第 1 号——业务办理》等法律、法规、规范性文件以及《公司 2022 年 限制性股票激励计划》（以下简称"本激励计划"）、《公司章程》的有关规定， 对公司 2022 年限制性股票激励计划首次授予部分第二个归属期及预留授予部分 第一个归属期归属名单进行审核，现发表核查意见如下： 本激励计划首次授予部分第二个归属期拟归属的 46 名激励对象及预留授予 部分第一个归属期拟归属的 5 名激励对象，符合《公司法》《证券法》等法律、 法规和规范性文件以及《公司章程》规定的任职资格，符合《管理办法》《上市 规则》等法律、法规和规范性文件规定的激励对象条件，符合公司本激励计划规 定的激励对象范围，其作为公司本激励计划激励对象的主体资格合法、有效，激 励对象获授的限制性股票的归属条件已成就。 监事会同意公司本次符合归属条件的激励对象名单，并 ...

重要内容提示： 1、符合本次第二类限制性股票归属条件的激励对象：51 人（其中首次授予 部分对象 46 名；预留授予对象 5 名） 2、拟归属的第二类限制性股票数量：164.0829 万股（含暂缓归属部分）， 占当前公司总股本的 0.9142%（其中首次授予部分第二个归属期第二类限制性股 票拟归属数量：157.9419 万股，预留授予部分第一个归属期第二类限制性股票拟 归属数量：6.1410 万股） 证券代码：300972 证券简称：万辰集团 公告编号：2024-102 福建万辰生物科技集团股份有限公司 关于公司 2022 年限制性股票激励计划首次授予部分第二个归属 期及预留授予部分第一个归属期归属条件成就的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 1、本激励计划采取的激励形式为第二类限制性股票。 3、归属股票来源：公司向激励对象定向发行的本公司人民币 A 股普通股股 票 4、归属时的授予价格：第一类激励对象 8.78 元/股 第二类激励对象 6.27 元/股 根据福建万辰生物科技集团股份有限公司（以下简称"公司"或"万辰集团"） 于 2024 ...

证券代码：300972 证券简称：万辰集团 公告编号：2024-101 福建万辰生物科技集团股份有限公司 （四）2022 年 10 月 17 日，公司召开 2022 年第一次临时股东大会，审议并 通过了《关于<公司 2022 年限制性股票激励计划（草案修订稿）>及其摘要的议 案》《关于<公司 2022 年限制性股票激励计划实施考核管理办法（修订稿）>的 议案》《关于提请股东大会授权董事会办理公司股权激励计划相关事宜的议案》 的议案。同日公司于巨潮资讯网（www.cninfo.com.cn)上披露了《关于 2022 年限 制性股票激励计划内幕信息知情人买卖公司股票情况的自查报告》。 （五）2022 年 10 月 21 日，公司召开第三届董事会第二十次会议与第三届 监事会第十八次会议，审议通过了《关于调整 2022 年限制性股票激励计划首次 授予激励对象名单及授予权益数量的议案》《关于向 2022 年限制性股票激励计 划激励对象首次授予限制性股票的议案》。公司独立董事对上述议案发表了独立 意见，认为调整本激励计划首次授予激励对象名单及授予权益数量符合相关规定， 首次授予条件已经成就，激励对象主体资格合法、有效，确 ...

华兴证券有限公司 关于福建万辰生物科技集团股份有限公司 控股子公司南京万好商业管理有限公司及南京万权商业管理有限公司 向控股子公司南京万昌商业管理有限公司提供财务资助的核查意见 华兴证券有限公司（以下简称"华兴证券"或"保荐机构"）作为福建万辰生 物科技集团股份有限公司（以下简称"万辰集团"或"公司"）向特定对象发行股 票并在创业板上市的持续督导保荐机构，根据《证券发行上市保荐业务管理办法》、 《深圳证券交易所创业板股票上市规则》、《深圳证券交易所上市公司自律监管指 引第 2 号——创业板上市公司规范运作》等有关规定的要求，对万辰集团控股子 公司南京万好商业管理有限公司（以下简称"南京万好"）及南京万权商业管理有 限公司（以下简称"南京万权"）向控股子公司南京万昌商业管理有限公司（以下 简称"南京万昌"）提供财务资助事项进行了审慎核查，核查意见如下： 重要内容提示： 1、万辰集团控股子公司南京万好拟向控股子公司南京万昌提供不超过 15,000 万元人民币的财务资助，控股子公司南京万权拟向南京万昌提供不超过 15,000 万 元人民币的财务资助，上述财务资助期限不超过 36 个月，并按实际使用资金与不 低于同类 ...